Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.67	38.75	96.34	24.49	42.75	157.15
Short-Term Investments	-	-	-	54.59	46.22	-
Cash & Short-Term Investments	10.67	38.75	96.34	79.08	88.97	157.15
Cash Growth	-82.23%	-59.77%	21.83%	-11.12%	-43.39%	3904.84%
Prepaid Expenses	0.93	3.18	3.88	3.32	2.53	2.97
Restricted Cash	-	-	-	0.22	-	-
Other Current Assets	2.92	2.28	1.97	1	0.4	0.28
Total Current Assets	14.52	44.21	102.18	83.61	91.9	160.4
Property, Plant & Equipment	0.74	0.93	1.18	1.4	1.48	1.87
Long-Term Investments	-	-	-	-	32.46	-
Other Long-Term Assets	0.06	0.07	0.58	0.64	0.65	0.62
Total Assets	15.31	45.21	103.95	85.65	126.49	162.88
Accounts Payable	1.39	1.3	3.33	1.43	2.82	3.63
Accrued Expenses	6.96	12.05	14.35	9.26	5.69	3.33
Current Portion of Long-Term Debt	0.54	1.62	1.62	1.62	-	2.55
Current Portion of Leases	0.31	0.28	0.25	0.14	0.36	0.25
Current Unearned Revenue	-	-	4.91	-	-	-
Total Current Liabilities	9.43	15.25	24.47	12.45	8.87	9.76
Long-Term Debt	-	0.12	1.72	3.29	4.88	1.92
Long-Term Leases	0.5	0.74	1.02	1.26	1.29	1.65
Other Long-Term Liabilities	-	0.28	0.24	0.16	0.07	0.12
Total Liabilities	9.93	16.39	27.44	17.16	15.12	13.46
Common Stock	-	0	0	0	0	0
Additional Paid-In Capital	279.97	279.09	273.74	218.35	214.69	210.27
Retained Earnings	-274.59	-250.27	-197.23	-149.31	-103.13	-60.84
Comprehensive Income & Other	-	-	-	-0.56	-0.18	-
Total Common Equity	5.39	28.82	76.51	68.49	111.37	149.43
Shareholders' Equity	5.39	28.82	76.51	68.49	111.37	149.43
Total Liabilities & Equity	15.31	45.21	103.95	85.65	126.49	162.88
Total Debt	1.35	2.77	4.61	6.32	6.53	6.38
Net Cash (Debt)	9.32	35.99	91.73	72.76	82.44	150.77
Net Cash Growth	-83.60%	-60.77%	26.07%	-11.74%	-45.32%	-
Net Cash Per Share	16.06	65.41	178.65	231.95	264.66	1887.41
Filing Date Shares Outstanding	1.07	0.56	0.55	0.53	0.31	0.31
Total Common Shares Outstanding	0.56	0.56	0.55	0.31	0.31	0.31
Working Capital	5.09	28.96	77.72	71.16	83.02	150.63
Book Value Per Share	9.56	51.18	139.85	217.64	355.56	481.81
Tangible Book Value	5.39	28.82	76.51	68.49	111.37	149.43
Tangible Book Value Per Share	9.56	51.18	139.85	217.64	355.56	481.81
Machinery	-	-	-	-	-	0.06
Leasehold Improvements	-	-	-	-	-	0.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.